The U.S. Food and Drug Administration says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used ...
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
Eli Lilly And Co. (NYSE:LLY) is ramping up its legal campaign against the compounding companies temporarily allowed to make ...
Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...
A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.
Last week, the FDA determined the shortage of Eli Lilly tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, ...
FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...
Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...
Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...
The Peptide Therapeutics Symposium brings together world leaders in peptide research from academia and the biopharmaceutical industries who are focused on advances in core technology pertinent to ...